254 related articles for article (PubMed ID: 28836822)
1. A review of ECG and QT interval measurement use in a public psychiatric inpatient setting.
Berling I; Gupta R; Bjorksten C; Prior F; Whyte IM; Berry S
Australas Psychiatry; 2018 Feb; 26(1):50-55. PubMed ID: 28836822
[TBL] [Abstract][Full Text] [Related]
2. [Risk management of QT-prolonging drugs by community pharmacists using a mobile electrocardiograph].
Shinozaki K
Yakugaku Zasshi; 2010 Nov; 130(11):1597-601. PubMed ID: 21048421
[TBL] [Abstract][Full Text] [Related]
3. Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.
Berling I; Isbister GK
Ann Emerg Med; 2015 Aug; 66(2):154-64. PubMed ID: 25639523
[TBL] [Abstract][Full Text] [Related]
4. [Drug induced QT prolongation].
Altmann D; Eggmann U; Ammann P
Wien Klin Wochenschr; 2008; 120(5-6):128-35. PubMed ID: 18365152
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study.
Girardin FR; Gex-Fabry M; Berney P; Shah D; Gaspoz JM; Dayer P
Am J Psychiatry; 2013 Dec; 170(12):1468-76. PubMed ID: 24306340
[TBL] [Abstract][Full Text] [Related]
6. An explainable algorithm for detecting drug-induced QT-prolongation at risk of torsades de pointes (TdP) regardless of heart rate and T-wave morphology.
Alahmadi A; Davies A; Royle J; Goodwin L; Cresswell K; Arain Z; Vigo M; Jay C
Comput Biol Med; 2021 Apr; 131():104281. PubMed ID: 33636421
[TBL] [Abstract][Full Text] [Related]
7. Sulpiride induced torsade de pointes.
Huang BH; Hsia CP; Chen CY
Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
[TBL] [Abstract][Full Text] [Related]
8. [Lengthening of QT interval by antipsychotic drugs].
Haverkamp W; Deuschle M
Nervenarzt; 2006 Mar; 77(3):276, 278-80, 282-4 passim. PubMed ID: 16052325
[TBL] [Abstract][Full Text] [Related]
9. [Psychiatric patients and QT interval monitoring].
Girardin F; Gaspoz JM
Rev Med Suisse; 2007 Apr; 3(106):945-8. PubMed ID: 17575970
[TBL] [Abstract][Full Text] [Related]
10. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.
Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK
Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028
[TBL] [Abstract][Full Text] [Related]
11. Emergency department approach to QTc prolongation.
Pourmand A; Mazer-Amirshahi M; Chistov S; Sabha Y; Vukomanovic D; Almulhim M
Am J Emerg Med; 2017 Dec; 35(12):1928-1933. PubMed ID: 28855066
[TBL] [Abstract][Full Text] [Related]
12. Measurement and Management of QT Interval Prolongation for General Physicians.
Indraratna P; Tardo D; Delves M; Szirt R; Ng B
J Gen Intern Med; 2020 Mar; 35(3):865-873. PubMed ID: 31654357
[TBL] [Abstract][Full Text] [Related]
13. [Long QT syndrome due to olanzapine administration].
Janion M; Dudek A; Sielski J; Janion-Sadowska A
Kardiol Pol; 2006 Sep; 64(9):986-8. PubMed ID: 17054030
[TBL] [Abstract][Full Text] [Related]
14. The relationship between atypical antipsychotics drugs, QT interval prolongation, and torsades de pointes: implications for clinical use.
Ruiz Diaz JC; Frenkel D; Aronow WS
Expert Opin Drug Saf; 2020 May; 19(5):559-564. PubMed ID: 32189527
[No Abstract] [Full Text] [Related]
15. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.
Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ
Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851
[TBL] [Abstract][Full Text] [Related]
16. [Antipsychotic drugs and cardiovascular safety: need for monitoring the QT interval].
Trojak B; Pinoit JM; André D; Bonin B; Gisselmann A
Presse Med; 2006 Apr; 35(4 Pt 2):699-704. PubMed ID: 16614617
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced QT prolongation and sudden death.
Del Rosario ME; Weachter R; Flaker GC
Mo Med; 2010; 107(1):53-8. PubMed ID: 20222297
[TBL] [Abstract][Full Text] [Related]
18. Drugs that cause Torsades de pointes and increase the risk of sudden cardiac death.
Wolbrette DL
Curr Cardiol Rep; 2004 Sep; 6(5):379-84. PubMed ID: 15306095
[TBL] [Abstract][Full Text] [Related]
19. QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update.
Beach SR; Celano CM; Sugrue AM; Adams C; Ackerman MJ; Noseworthy PA; Huffman JC
Psychosomatics; 2018; 59(2):105-122. PubMed ID: 29275963
[TBL] [Abstract][Full Text] [Related]
20. Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medications and related drug-drug interactions in a cohort of psychiatry patients.
Das B; Rawat VS; Ramasubbu SK; Kumar B
Therapie; 2019 Dec; 74(6):599-609. PubMed ID: 31053339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
